Tbo-filgrastim is a granulocyte colony stimulating factor (G-CSF). Tbo-filgrastim is a man-made form of a protein that stimulates the growth of white blood cells in your body. White blood cells help your body fight against infection. Tbo-filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by receiving chemotherapy with certain cancer medications. Tbo-filgrastim may also be used for purposes not listed in this medication guide.
Granix is a medication used in the treatment of severe neutropenia. The active ingredient of the medication is a drug called TBO-filgrastim. The purpose of treatment is to reduce the duration of neutropenia that occurs in patients receiving myelosuppressive chemotherapeutic drugs. Granix is administered as a subcutaneous injection after the patient has received chemotherapy, usually after 24 hours.